Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Tests a home music app for adults with hard-to-treat epilepsy

Tests music played at home through a web app for adults with epilepsy.

Plain-language title generated from the registry record
Registry title: Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application

Key facts

Where
Lebanon and Worcester, United StatesSee the 2 sites

Where in United States

  • Dartmouth Hitchcock Medical CenterLebanon, United StatesTaking people
  • University of Massachusetts Chan Medical SchoolWorcester, United StatesNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Dartmouth-Hitchcock Medical Center
Trial code
NCT06425029
Record updated
20 May 2026
Original description
This is a prospective, placebo-controlled, double-blinded randomized study of self-administered auditory intervention in a naturalistic home environment.Read full original descriptionShow less

SONATA: Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application

This is a prospective, placebo-controlled, double-blinded randomized study of self-administered auditory intervention in a naturalistic home environment.

Inclusion: Adults with medication-refractory focal epilepsy who have undergone RNS implantation at least six months prior and are in the judgement of the treating physician on a stable RNS regimen in terms of stimulation; Willing to attend all study visits and complete all required study procedures; Access to private or public wireless data service at regular intervals; Access to personal mobile device.

Exclusion: Documentation of a musicogenic, or auditory-triggered focal seizure semiology; Participant is unable to reasonably participate in study tasks as determined by the investigator; Inability to obtain informed consent from the patient or legally authorized representative.

ClinicalTrials.gov NCT06425029